Epigenetic regulation of NANOG by miR-302 cluster-MBD2 completes induced pluripotent stem cell reprogramming

Man Ryul Lee, Nutan Prasain, Hee Don Chae, Young June Kim, Charlie Mantel, Mervin Yoder, Hal Broxmeyer

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

While most somatic cells undergoing induced pluripotent stem (iPS) cell reprogramming with Yamanaka factors accumulate at stable partially reprogrammed stages, the molecular mechanisms required to achieve full reprogramming are unknown. MicroRNAs (miRNAs) fine-tune mRNA translation and are implicated in reprogramming, but miRNA functional targets critical for complete iPS cell reprogramming remain elusive. We identified methyl- DNA binding domain protein 2 (MBD2) as an epigenetic suppressor, blocking full reprogramming of somatic to iPS cells through direct binding to NANOG promoter elements preventing transcriptional activation. When we overexpressed miR-302 cluster we observed a significant increase in conversion of partial to fully reprogrammed iPS cells by suppressing MBD2 expression, thereby increasing NANOG expression. Thus, expression of exogenous miR- 302 cluster (without miR-367) is efficient in attaining a fully reprogrammed iPS state in partially reprogrammed cells by relieving MBD2-mediated inhibition of NANOG expression. Our studies provide a direct molecular mechanism involved in generating complete human iPS cell reprogramming to study disease pathogenesis, drug screening, and for potential cell-based therapies.

Original languageEnglish
Pages (from-to)666-681
Number of pages16
JournalStem Cells
Volume31
Issue number4
DOIs
StatePublished - Apr 2013

Fingerprint

Induced Pluripotent Stem Cells
DNA-Binding Proteins
Epigenomics
MicroRNAs
Preclinical Drug Evaluations
Protein Biosynthesis
Cell- and Tissue-Based Therapy
Transcriptional Activation
Cellular Reprogramming

Keywords

  • Epigenetics
  • Induced pluripotent stem cells
  • MicroRNA
  • Reprogramming

ASJC Scopus subject areas

  • Cell Biology
  • Developmental Biology
  • Molecular Medicine

Cite this

Epigenetic regulation of NANOG by miR-302 cluster-MBD2 completes induced pluripotent stem cell reprogramming. / Lee, Man Ryul; Prasain, Nutan; Chae, Hee Don; Kim, Young June; Mantel, Charlie; Yoder, Mervin; Broxmeyer, Hal.

In: Stem Cells, Vol. 31, No. 4, 04.2013, p. 666-681.

Research output: Contribution to journalArticle

Lee, Man Ryul ; Prasain, Nutan ; Chae, Hee Don ; Kim, Young June ; Mantel, Charlie ; Yoder, Mervin ; Broxmeyer, Hal. / Epigenetic regulation of NANOG by miR-302 cluster-MBD2 completes induced pluripotent stem cell reprogramming. In: Stem Cells. 2013 ; Vol. 31, No. 4. pp. 666-681.
@article{e664d9ab48264806af9305b80e757dbd,
title = "Epigenetic regulation of NANOG by miR-302 cluster-MBD2 completes induced pluripotent stem cell reprogramming",
abstract = "While most somatic cells undergoing induced pluripotent stem (iPS) cell reprogramming with Yamanaka factors accumulate at stable partially reprogrammed stages, the molecular mechanisms required to achieve full reprogramming are unknown. MicroRNAs (miRNAs) fine-tune mRNA translation and are implicated in reprogramming, but miRNA functional targets critical for complete iPS cell reprogramming remain elusive. We identified methyl- DNA binding domain protein 2 (MBD2) as an epigenetic suppressor, blocking full reprogramming of somatic to iPS cells through direct binding to NANOG promoter elements preventing transcriptional activation. When we overexpressed miR-302 cluster we observed a significant increase in conversion of partial to fully reprogrammed iPS cells by suppressing MBD2 expression, thereby increasing NANOG expression. Thus, expression of exogenous miR- 302 cluster (without miR-367) is efficient in attaining a fully reprogrammed iPS state in partially reprogrammed cells by relieving MBD2-mediated inhibition of NANOG expression. Our studies provide a direct molecular mechanism involved in generating complete human iPS cell reprogramming to study disease pathogenesis, drug screening, and for potential cell-based therapies.",
keywords = "Epigenetics, Induced pluripotent stem cells, MicroRNA, Reprogramming",
author = "Lee, {Man Ryul} and Nutan Prasain and Chae, {Hee Don} and Kim, {Young June} and Charlie Mantel and Mervin Yoder and Hal Broxmeyer",
year = "2013",
month = "4",
doi = "10.1002/stem.1302",
language = "English",
volume = "31",
pages = "666--681",
journal = "Stem Cells",
issn = "1066-5099",
publisher = "AlphaMed Press",
number = "4",

}

TY - JOUR

T1 - Epigenetic regulation of NANOG by miR-302 cluster-MBD2 completes induced pluripotent stem cell reprogramming

AU - Lee, Man Ryul

AU - Prasain, Nutan

AU - Chae, Hee Don

AU - Kim, Young June

AU - Mantel, Charlie

AU - Yoder, Mervin

AU - Broxmeyer, Hal

PY - 2013/4

Y1 - 2013/4

N2 - While most somatic cells undergoing induced pluripotent stem (iPS) cell reprogramming with Yamanaka factors accumulate at stable partially reprogrammed stages, the molecular mechanisms required to achieve full reprogramming are unknown. MicroRNAs (miRNAs) fine-tune mRNA translation and are implicated in reprogramming, but miRNA functional targets critical for complete iPS cell reprogramming remain elusive. We identified methyl- DNA binding domain protein 2 (MBD2) as an epigenetic suppressor, blocking full reprogramming of somatic to iPS cells through direct binding to NANOG promoter elements preventing transcriptional activation. When we overexpressed miR-302 cluster we observed a significant increase in conversion of partial to fully reprogrammed iPS cells by suppressing MBD2 expression, thereby increasing NANOG expression. Thus, expression of exogenous miR- 302 cluster (without miR-367) is efficient in attaining a fully reprogrammed iPS state in partially reprogrammed cells by relieving MBD2-mediated inhibition of NANOG expression. Our studies provide a direct molecular mechanism involved in generating complete human iPS cell reprogramming to study disease pathogenesis, drug screening, and for potential cell-based therapies.

AB - While most somatic cells undergoing induced pluripotent stem (iPS) cell reprogramming with Yamanaka factors accumulate at stable partially reprogrammed stages, the molecular mechanisms required to achieve full reprogramming are unknown. MicroRNAs (miRNAs) fine-tune mRNA translation and are implicated in reprogramming, but miRNA functional targets critical for complete iPS cell reprogramming remain elusive. We identified methyl- DNA binding domain protein 2 (MBD2) as an epigenetic suppressor, blocking full reprogramming of somatic to iPS cells through direct binding to NANOG promoter elements preventing transcriptional activation. When we overexpressed miR-302 cluster we observed a significant increase in conversion of partial to fully reprogrammed iPS cells by suppressing MBD2 expression, thereby increasing NANOG expression. Thus, expression of exogenous miR- 302 cluster (without miR-367) is efficient in attaining a fully reprogrammed iPS state in partially reprogrammed cells by relieving MBD2-mediated inhibition of NANOG expression. Our studies provide a direct molecular mechanism involved in generating complete human iPS cell reprogramming to study disease pathogenesis, drug screening, and for potential cell-based therapies.

KW - Epigenetics

KW - Induced pluripotent stem cells

KW - MicroRNA

KW - Reprogramming

UR - http://www.scopus.com/inward/record.url?scp=84875787631&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875787631&partnerID=8YFLogxK

U2 - 10.1002/stem.1302

DO - 10.1002/stem.1302

M3 - Article

C2 - 23255147

AN - SCOPUS:84875787631

VL - 31

SP - 666

EP - 681

JO - Stem Cells

JF - Stem Cells

SN - 1066-5099

IS - 4

ER -